MedTrace Logo

Penicillin Allergy Delabeling Project

NCT05090527 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2024-02-09

No results posted yet for this study

Summary

A investigational study to establish:

1. A validated cllinical pathway for delabeling declared Penicillin allergiy outside allergologic departments.
2. A survey to examine anesthesiologists attitudes and knowledge about penicillin delabeling.
3. A qualitative focus group study investigating barriers and facilitators in penicillin delabeling among hospital nurses and physichians.

2\. Implement the pathway for delabeling declared penicillin allergy outside allergologic clinics across the Western Norway health region.

Conditions

  • Penicillin Allergy

Interventions

DIAGNOSTIC_TEST

Risk stratification

advanced penicillin challenge after risk stratification

Sponsors & Collaborators

  • Helse Fonna

    collaborator OTHER

  • Helse Forde

    collaborator OTHER

  • Haraldsplass Deaconess Hospital

    collaborator OTHER

  • Helse Stavanger HF

    collaborator OTHER_GOV

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Torgeir Storaas, phd · RAAO vest

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-28
Primary Completion
2023-04-01
Completion
2023-05-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05090527 on ClinicalTrials.gov